Legend: : Special Mention  : Important : Very Important : Key Development |
| |
| |
Review article: the role of surgery in gastro-oesophageal reflux disease.
N Vakil, Aliment Pharmacol Ther. 2007 Jun 15:1365-72 |
| |
AGA Institute technical review on the use of endoscopic therapy for gastroesophageal reflux disease.
GW Falk, MB Fennerty, RI Rothstein, Gastroenterology. 2006 Oct:1315-36 |
| |
Clinical trials evaluating endoscopic GERD treatments: is it time for a moratorium on the clinical use of these procedures?
WJ Hogan, Am J Gastroenterol. 2006 Mar:437-9 |
| |
Detection of Barrett's esophagus after endoscopic healing of erosive esophagitis.
S Hanna, A Rastogi, AP Weston, F Totta, R Schmitz, S Mathur, D McGregor, R Cherian, P Sharma, Am J Gastroenterol. 2006 Jul:1416-20 |
| |
Effects of partial (Belsey Mark IV) and complete (Nissen) fundoplication on proximal gastric function and esophagogastric junction dynamics.
RC Scheffer, M Samsom, GS Hebbard, HG Gooszen, Am J Gastroenterol. 2006 Mar:479-87 |
| |
Gastro-oesophageal reflux disease.
M Fox, I Forgacs, BMJ. 2006 Jan 14:88-93 |
| |
Long term failure of endoscopic gastroplication (EndoCinch).
I Schiefke, A Zabel-Langhennig, S Neumann, J Feisthammel, J Moessner, K Caca, Gut. 2005 Jun:752-8 |
| |
On-demand therapy for gastroesophageal reflux disease.
DC Metz, JM Inadomi, CW Howden, SJ van Zanten, P Bytzer, Am J Gastroenterol. 2007 Mar:642-53 |
| |
A new esophageal stent design (Niti-S stent) for the prevention of migration: a prospective study in 42 patients.
EM Verschuur, MY Homs, EW Steyerberg, J Haringsma, PJ Wahab, EJ Kuipers, PD Siersema, Gastrointest Endosc. 2006 Jan:134-40 |
| |
A prospective study of gastric acid analysis and esophageal acid exposure in patients with gastroesophageal reflux refractory to medical therapy.
SK Ahlawat, R Mohi-Ud-Din, DC Williams, KA Maher, SB Benjamin, Dig Dis Sci. 2005 Nov:2019-24 |
| |
A randomized prospective comparison of self-expandable plastic stents and partially covered self-expandable metal stents in the palliation of malignant esophageal dysphagia.
M Conio, A Repici, G Battaglia, G De Pretis, L Ghezzo, M Bittinger, H Messmann, JF Demarquay, S Blanchi, M Togni, R Conigliaro, R Filiberti, Am J Gastroenterol. 2007 Dec:2667-77 |
| |
AGA Institute medical position statement on the use of endoscopic therapy for gastroesophageal reflux disease.
GW Falk, MB Fennerty, RI Rothstein, Gastroenterology. 2006 Oct:1313-4 |
| |
Assessment of dietary nutrients that influence perception of intra-oesophageal acid reflux events in patients with gastro-oesophageal reflux disease.
M Shapiro, C Green, JM Bautista, R Dekel, S Risner-Adler, R Whitacre, E Graver, R Fass, Aliment Pharmacol Ther. 2007 Jan 1:93-101 |
| |
Association between dinner-to-bed time and gastro-esophageal reflux disease.
Y Fujiwara, A Machida, Y Watanabe, M Shiba, K Tominaga, T Watanabe, N Oshitani, K Higuchi, T Arakawa, Am J Gastroenterol. 2005 Dec:2633-6 |
| |
Association of body mass index with heartburn, regurgitation and esophagitis: results of the Progression of Gastroesophageal Reflux Disease study.
M Nocon, J Labenz, D Jaspersen, W Meyer-Sabellek, M Stolte, T Lind, P Malfertheiner, SN Willich, J Gastroenterol Hepatol. 2007 Nov:1728-31 |
| |
Body mass index and chronic unexplained gastrointestinal symptoms: an adult endoscopic population based study.
P Aro, J Ronkainen, NJ Talley, T Storskrubb, E Bolling-Sternevald, L Agréus, Gut. 2005 Oct:1377-83 |
| |
Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a metaanalysis.
F Cremonini, J Wise, P Moayyedi, NJ Talley, Am J Gastroenterol. 2005 Jun:1226-32 |
| |
Dilated intercellular spaces and acid reflux at the distal and proximal oesophagus in patients with non-erosive gastro-oesophageal reflux disease.
R Caviglia, M Ribolsi, M Gentile, C Rabitti, S Emerenziani, MP Guarino, T Petitti, M Cicala, Aliment Pharmacol Ther. 2007 Mar 1:629-36 |
| |
Does Barrett's oesophagus develop over time in patients with chronic gastro-oesophageal reflux disease?
J Stoltey, H Reeba, N Ullah, P Sabhaie, L Gerson, Aliment Pharmacol Ther. 2007 Jan 1:83-91 |
| |
Effect of stent size on complications and recurrent dysphagia in patients with esophageal or gastric cardia cancer.
EM Verschuur, EW Steyerberg, EJ Kuipers, PD Siersema, Gastrointest Endosc. 2007 Apr:592-601 |
| |
Extraoesophageal manifestations of gastro-oesophageal reflux.
J Poelmans, J Tack, Gut. 2005 Oct:1492-9 |
| |
Gastric fullness, physical activity, and proximal extent of gastroesophageal reflux.
S Emerenziani, X Zhang, K Blondeau, J Silny, J Tack, J Janssens, D Sifrim, Am J Gastroenterol. 2005 Jun:1251-6 |
| |
Gastro-oesophageal reflux disease in chronic laryngitis: prevalence and response to acid-suppressive therapy.
CS Qua, CH Wong, K Gopala, KL Goh, Aliment Pharmacol Ther. 2007 Feb 1:287-95 |
| |
Gastroesophageal reflux disease and Barrett's esophagus.
JJ Bergman, Endoscopy. 2005 Jan:8-18 |
| |
Gastroesophageal reflux symptoms during and after pregnancy: a longitudinal study.
E Rey, F Rodriguez-Artalejo, MA Herraiz, P Sanchez, A Alvarez-Sanchez, M Escudero, M Diaz-Rubio, Am J Gastroenterol. 2007 Nov:2395-400 |
| |
Improved diagnosis of gastro-oesophageal reflux in patients with unexplained chronic cough.
K Blondeau, LJ Dupont, V Mertens, J Tack, D Sifrim, Aliment Pharmacol Ther. 2007 Mar 15:723-32 |
| |
Is aperistalsis with complete lower esophageal sphincter relaxation an early stage of classic achalasia?
JH Kim, PL Rhee, SS Lee, H Lee, YS Choi, HJ Son, JJ Kim, JC Rhee, J Gastroenterol Hepatol. 2007 Apr:536-41 |
| |
Is ineffective oesophageal motility associated with reflux oesophagitis?
F Fornari, SM Callegari-Jacques, PJ Scussel, LF Madalosso, EF Barros, SG Barros, Eur J Gastroenterol Hepatol. 2007 Sep:783-7 |
| |
Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: systematic review and meta-analysis.
N Vakil, P Moayyedi, MB Fennerty, NJ Talley, Gastroenterology. 2006 Aug:390-401; quiz 659-60 |
| |
Long-term results of radiofrequency energy delivery for the treatment of GERD: sustained improvements in symptoms, quality of life, and drug use at 4-year follow-up.
A Reymunde, N Santiago, Gastrointest Endosc. 2007 Mar:361-6 |
| |
Mortality associated with Barrett's esophagus and gastroesophageal reflux disease diagnoses-a population-based cohort study.
M Solaymani-Dodaran, RF Logan, J West, T Card, Am J Gastroenterol. 2005 Dec:2616-21 |
| |
Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjects.
F Zerbib, SB des Varannes, S Roman, P Pouderoux, F Artigue, U Chaput, F Mion, F Caillol, E Verin, G Bommelaer, P Ducrotté, JP Galmiche, D Sifrim, Aliment Pharmacol Ther. 2005 Nov 15:1011-21 |
| |
Obesity is an independent risk factor for GERD symptoms and erosive esophagitis.
HB El-Serag, DY Graham, JA Satia, L Rabeneck, Am J Gastroenterol. 2005 Jun:1243-50 |
| |
Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastro-oesophageal reflux disease in Western patients with non-ulcer dyspepsia.
N Vakil, NJ Talley, M Stolte, M Sundin, O Junghard, E Bolling-Sternevald, Aliment Pharmacol Ther. 2006 Jul 1:55-63 |
| |
Prevalence of acid reflux in functional dyspepsia and its association with symptom profile.
J Tack, P Caenepeel, J Arts, KJ Lee, D Sifrim, J Janssens, Gut. 2005 Oct:1370-6 |
| |
Reflux symptoms in professional opera choristers.
G Cammarota, G Masala, R Cianci, D Palli, P Capaccio, A Schindler, L Cuoco, J Galli, E Ierardi, O Cannizzaro, M Caselli, MP Dore, B Bendinelli, G Gasbarrini, Gastroenterology. 2007 Mar:890-8 |
| |
Relevance of ineffective esophageal motility and hyperactive acid sensitization in patients with gastroesophageal reflux.
SJ Hong, BM Ko, IS Jung, CB Ryu, JH Moon, JY Cho, JO Kim, JS Lee, MS Lee, CS Shim, BS Kim, J Gastroenterol Hepatol. 2007 Oct:1662-5 |
| |
Review article: gastro-oesophageal reflux disease as a functional gastrointestinal disorder.
PJ Kahrilas, Aliment Pharmacol Ther. 2004 Nov:50-5 |
| |
Review article: how valuable are proton-pump inhibitors in establishing a diagnosis of gastro-oesophageal reflux disease?
N Vakil, Aliment Pharmacol Ther. 2005 Aug:64-9 |
| |
Review article: quality-of-life issues in gastro-oesophageal reflux disease.
EM Quigley, AP Hungin, Aliment Pharmacol Ther. 2005 Aug:41-7 |
| |
Review article: role of pepsin and bile in gastro-oesophageal reflux disease.
J Tack, Aliment Pharmacol Ther. 2005 Aug:48-54 |
| |
Review article: the long-term use of proton-pump inhibitors.
AS Raghunath, C O'Morain, RC McLoughlin, Aliment Pharmacol Ther. 2005 Aug:55-63 |
| |
Review article: the management of achalasia - a comparison of different treatment modalities.
JM Lake, RK Wong, Aliment Pharmacol Ther. 2006 Sep 15:909-18 |
| |
Review article: the nature of oesophageal injury in gastro-oesophageal reflux disease.
G De Hertogh, N Ectors, P Van Eyken, K Geboes, Aliment Pharmacol Ther. 2006 Sep:17-26 |
| |
Review article: the pathophysiology of gastro-oesophageal reflux disease.
GE Boeckxstaens, Aliment Pharmacol Ther. 2007 Jul 15:149-60 |
| |
Review article: the role of bile and pepsin in the pathophysiology and treatment of gastro-oesophageal reflux disease.
J Tack, Aliment Pharmacol Ther. 2006 Sep:10-6 |
| |
Stretta: ahead of its time or has its time passed?
CD Smith, Gastrointest Endosc. 2007 Mar:373-4 |
| |
Sustained improvement in symptoms of GERD and antisecretory drug use: 4-year follow-up of the Stretta procedure.
MD Noar, S Lotfi-Emran, Gastrointest Endosc. 2007 Mar:367-72 |
| |
Testing the association between gastroesophageal reflux and apnea in infants.
H Mousa, FW Woodley, M Metheney, J Hayes, J Pediatr Gastroenterol Nutr. 2005 Aug:169-77 |
| |
The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus.
N Vakil, SV van Zanten, P Kahrilas, J Dent, R Jones, Global Consensus Group, Am J Gastroenterol. 2006 Aug:1900-20; quiz 1943 |
| |
The yield and safety of string capsule endoscopy in patients with dysphagia.
N Gilani, S Stipho, MS Shaukat, R Akins, FC Ramirez, Gastrointest Endosc. 2007 Dec:1091-5 |
| |
Acid reflux event detection using the Bravo wireless versus the Slimline catheter pH systems: why are the numbers so different?
JE Pandolfino, Q Zhang, MA Schreiner, S Ghosh, MP Roth, PJ Kahrilas, Gut. 2005 Dec:1687-92 |
| |
Association between reflux oesophagitis and features of the metabolic syndrome in Japan.
F Moki, M Kusano, M Mizuide, Y Shimoyama, O Kawamura, H Takagi, T Imai, M Mori, Aliment Pharmacol Ther. 2007 Oct 1:1069-75 |
| |
Barrett's esophagus and medications that relax the lower esophageal sphincter.
DA Corley, TR Levin, LA Habel, PA Buffler, Am J Gastroenterol. 2006 May:937-44 |
| |
Cell proliferation of squamous epithelium in gastro-oesophageal reflux disease: correlations with clinical, endoscopic and morphological data.
L Mastracci, F Grillo, P Spaggiari, P Dulbecco, S Pigozzi, V Savarino, R Fiocca, Aliment Pharmacol Ther. 2007 Mar 1:637-45 |
| |
Cost of gastro-oesophageal reflux disease to the employer: a perspective from the United States.
RA Brook, P Wahlqvist, NL Kleinman, MA Wallander, SM Campbell, JE Smeeding, Aliment Pharmacol Ther. 2007 Sep 15:889-98 |
| |
Double stenting of oesophagus and airways in palliative treatment of patients with oesophageal cancer is efficient but associated with a high morbidity.
S Lecleire, M Antonietti, F Di Fiore, E Ben-Soussan, S Bota, MF Hellot, L Thiberville, P Michel, E Lerebours, P Ducrotté, Aliment Pharmacol Ther. 2007 Apr 15:955-63 |
| |
Dysphagia associated with gastroesophageal reflux disease is improved by proton pump inhibitor.
K Oda, R Iwakiri, M Hara, K Watanabe, A Danjo, R Shimoda, A Kikkawa, A Ootani, H Sakata, S Tsunada, K Fujimoto, Dig Dis Sci. 2005 Oct:1921-6 |
| |
Effects and mechanism of changes of local neurotransmitters in rats' pylorus and bile reflux to the stomach with stress ulcer.
C Min, L Hesheng, C Jihong, T Qiaoyun, L Xianzhen, S Chireyeth, Dig Dis Sci. 2005 Oct:1898-903 |
| |
Endoscopic capsule endoscope delivery for patients with dysphagia, anatomical abnormalities, or gastroparesis.
EJ Carey, RI Heigh, DE Fleischer, Gastrointest Endosc. 2004 Mar:423-6 |
| |
Environmental risk factors in the development of adenocarcinoma of the oesophagus or gastric cardia: a cross-sectional study in a Dutch cohort.
PJ DE Jonge, LM Wolters, EW Steyerberg, H VAN Dekken, JG Kusters, EJ Kuipers, PD Siersema, Aliment Pharmacol Ther. 2007 Jul 1:31-9 |
| |
Esophageal motility differences among aged patients with achalasia: a Taiwan report.
SK Chuah, CS Changchien, KL Wu, TH Hu, CM Kuo, YC Chiu, KW Chiu, CH Kuo, SS Chiou, CM Lee, J Gastroenterol Hepatol. 2007 Nov:1737-40 |
| |
Evolving role of self-expanding metal stents in the treatment of malignant dysphagia and fistulas.
WA Ross, F Alkassab, PM Lynch, GD Ayers, J Ajani, JH Lee, M Bismar, Gastrointest Endosc. 2007 Jan:70-6 |
| |
Histological effects of esomeprazole therapy on the squamous epithelium of the distal oesophagus.
M Vieth, M Kulig, A Leodolter, E Nauclér, D Jaspersen, J Labenz, W Meyer-Sabellek, T Lind, S Willich, P Malfertheiner, M Stolte, Aliment Pharmacol Ther. 2006 Jan 15:313-9 |
| |
Is gastroesophageal reflux disease really a life-long disease: do babies who regurgitate grow up to be adults with GERD complications?
BD Gold, Am J Gastroenterol. 2006 Mar:641-4 |
| |
Is the questionnaire for the assessment of gastroesophageal reflux useful for diabetic patients?
F Kinekawa, F Kubo, K Matsuda, M Kobayashi, Y Furuta, H Yamanouchi, H Inoue, H Kurata, Y Uchida, S Kuriyama, Scand J Gastroenterol. 2005 Sep:1017-20 |
| |
Lifestyle factors and symptoms of gastro-oesophageal reflux -- a population-based study.
M Nocon, J Labenz, SN Willich, Aliment Pharmacol Ther. 2006 Jan 1:169-74 |
| |
Long-term treatment of patients with gastro-oesophageal reflux disease in routine care - results from the ProGERD study.
M Nocon, J Labenz, D Jaspersen, W Meyer-Sabellek, M Stolte, T Lind, P Malfertheiner, SN Willich, Aliment Pharmacol Ther. 2007 Mar 15:715-22 |
| |
Lugol chromoendoscopy as a diagnostic tool in so-called endoscopy-negative GERD.
I Yoshikawa, M Yamasaki, T Yamasaki, K Kume, M Otsuki, Gastrointest Endosc. 2005 Nov:698-703; quiz 752, 754 |
| |
Multichannel intraluminal impedance monitoring in the evaluation of patients with non-obstructive Dysphagia.
JM Conchillo, NQ Nguyen, M Samsom, RH Holloway, AJ Smout, Am J Gastroenterol. 2005 Dec:2624-32 |
| |
Overlap of gastro-oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population.
HK Jung, S Halder, M McNally, GR Locke 3rd, CD Schleck, AR Zinsmeister, NJ Talley, Aliment Pharmacol Ther. 2007 Aug 1:453-61 |
| |
Palliation of malignant esophageal Dysphagia: would you like plastic or metal?
GG Ginsberg, Am J Gastroenterol. 2007 Dec:2678-9 |
| |
Palliative treatment of malignant dysphagia with self-expanding metal stents: a 12-year experience.
M Sundel&oeig;f, D Ringby, D Stockeld, L Granstr&oeig;m, E Jonas, J Freedman, Scand J Gastroenterol. 2007 Jan:11-6 |
| |
Patients with functional heartburn are more likely to report retrosternal discomfort during wireless pH monitoring.
YC Lee, HP Wang, HM Chiu, SP Huang, CH Tu, MS Wu, JT Lin, Gastrointest Endosc. 2005 Dec:834-41 |
| |
Persisting symptoms and decreased health-related quality-of-life in a cross-sectional study of treated achalasia patients.
R Frankhuisen, MA van Herwaarden, R Heijkoop, AJ Smout, A Baron, JR Vermeijden, HG Gooszen, M Samsom, Aliment Pharmacol Ther. 2007 Sep 15:899-904 |
| |
Pharyngeal reflux episodes at pH 5 in healthy volunteers.
O Andersson, R Ylitalo, C Finizia, M Bove, R Magnus, Scand J Gastroenterol. 2006 Feb:138-43 |
| |
Polyflex stents for malignant oesophageal and oesophagogastric stricture: a prospective, multicentric study.
R Conigliaro, G Battaglia, A Repici, G De Pretis, L Ghezzo, M Bittinger, H Messmann, JF Demarquay, M Togni, S Blanchi, R Filiberti, M Conio, Eur J Gastroenterol Hepatol. 2007 Mar:195-203 |
| |
Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese.
I Mishima, K Adachi, N Arima, K Amano, T Takashima, M Moritani, K Furuta, Y Kinoshita, Scand J Gastroenterol. 2005 Sep:1005-9 |
| |
Prevalence of epigastric pain, heartburn and acid regurgitation in adolescents and their parents: evidence for intergenerational association.
LJ Murray, P McCarron, RB McCorry, CA Boreham, CP McGartland, BT Johnston, Eur J Gastroenterol Hepatol. 2007 Apr:297-303 |
| |
Prevalence of upper gastrointestinal tract findings in patients with noncardiac chest pain versus those with gastroesophageal reflux disease (GERD)-related symptoms: results from a national endoscopic
R Dickman, N Mattek, J Holub, D Peters, R Fass, Am J Gastroenterol. 2007 Jun:1173-9 |
| |
Programme of stepping down from twice daily proton pump inhibitor therapy for symptomatic gastro-oesophageal reflux disease associated with a formulary change at a VA medical center.
GA Coté, MR Ferreira, K Rozenberg-Ben-Dror, CW Howden, Aliment Pharmacol Ther. 2007 Mar 15:709-14 |
| |
Relationship between intragastric acid control and healing status in the treatment of moderate to severe erosive oesophagitis.
PO Katz, GG Ginsberg, PE Hoyle, MB Sostek, JT Monyak, DG Silberg, Aliment Pharmacol Ther. 2007 Mar 1:617-28 |
| |
Review article: extraoesophageal manifestations of gastro-oesophageal reflux disease.
JE Richter, Aliment Pharmacol Ther. 2005 Aug:70-80 |
| |
Review article: gastro-oesophageal reflux disease--the extent of the problem.
P Moayyedi, AT Axon, Aliment Pharmacol Ther. 2005 Aug:11-9 |
| |
Review article: gastro-oesophageal reflux disease--the health economic implications.
J Mason, AP Hungin, Aliment Pharmacol Ther. 2005 Aug:20-31 |
| |
Review article: Helicobacter pylori and gastro-oesophageal reflux disease.
B Delaney, K McColl, Aliment Pharmacol Ther. 2005 Aug:32-40 |
| |
Review: what do we mean by GERD?--definition and diagnosis.
R Jones, JP Galmiche, Aliment Pharmacol Ther. 2005 Aug:2-10 |
| |
Role of clinical presentation in diagnosing reflux-related non-cardiac chest pain.
S Mousavi, J Tosi, R Eskandarian, M Zahmatkesh, J Gastroenterol Hepatol. 2007 Feb:218-21 |
| |
Severe gastro-oesophageal reflux symptoms in relation to anxiety, depression and coping in a population-based study.
C Jansson, H Nordenstedt, MA Wallander, S Johansson, R Johnsen, K Hveem, J Lagergren, Aliment Pharmacol Ther. 2007 Sep 1:683-91 |
| |
Simultaneous recordings of oesophageal acid exposure with conventional pH monitoring and a wireless system (Bravo).
SB des Varannes, F Mion, P Ducrotté, F Zerbib, P Denis, T Ponchon, R Thibault, JP Galmiche, Gut. 2005 Dec:1682-6 |
| |
Single-session, graded esophageal dilation without fluoroscopy in outpatients with lower esophageal (Schatzki's) rings: a prospective, long-term follow-up study.
SN Sgouros, K Vassiliadis, C Bergele, J Vlachogiannakos, G Stefanidis, A Mantides, J Gastroenterol Hepatol. 2007 May:653-7 |
| |
Stent placement or brachytherapy for palliation of dysphagia from esophageal cancer: a prognostic model to guide treatment selection.
EW Steyerberg, MY Homs, A Stokvis, ML Essink-Bot, PD Siersema, for the SIREC Study Group, Gastrointest Endosc. 2005 Sep:333-40 |
| |
The contribution of elevated gastric pressure to prevention of gastroesophageal reflux in several different antireflux procedures.
O Ate_, G Hakguder, M Olguner, Y Kart, F Akgur, Dig Dis Sci. 2005 Nov:2129-33 |
| |
The frontiers of reflux disease.
N Vakil, Dig Dis Sci. 2006 Nov:1887-95 |
| |
The role of transsphincteric pressure and proximal gastric volume in acid reflux before and after fundoplication.
RC Scheffer, HG Gooszen, GS Hebbard, M Samsom, Gastroenterology. 2005 Dec:1900-9 |
| |
The use of the internet in data assimilation in rare diseases.
R Bedgood, R Sadurski, RR Schade, Dig Dis Sci. 2007 Feb:307-12 |
| |
The value of ambulatory 24 hr esophageal pH monitoring in clinical practice in patients who were referred with persistent gastroesophageal reflux disease (GERD)-related symptoms while on standard dose
JM Bautista, WM Wong, G Pulliam, RF Esquivel, R Fass, Dig Dis Sci. 2005 Oct:1909-15 |
| |
Transient lower esophageal sphincter relaxations do not result from passive opening of the cardia by gastric distention.
BT Massey, C Simuncak, NJ LeCapitaine-Dana, S Pudur, Gastroenterology. 2006 Jan:89-95 |
| Supplementary evidence: |
| |
Diagnostic value of the proton pump inhibitor test for gastro-oesophageal reflux disease in primary care.
MC Aanen, BL Weusten, ME Numans, NJ de Wit, A Baron, AJ Smout, Aliment Pharmacol Ther. 2006 Nov 1:1377-84 |
| |
Epidemiology of gastro-oesophageal reflux disease: a systematic review.
J Dent, HB El-Serag, MA Wallander, S Johansson, Gut. 2005 May:710-7 |
| |
Hygiene could affect GERD prevalence independently: a population-based study in Tehran.
M Nouraie, AR Radmard, H Zaer-Rezaii, H Razjouyan, S Nasseri-Moghaddam, R Malekzadeh, Am J Gastroenterol. 2007 Jul:1353-60 |
| |
Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
M Miyamoto, K Haruma, M Kuwabara, M Nagano, T Okamoto, M Tanaka, J Gastroenterol Hepatol. 2007 May:639-44 |
| |
Neuromuscular treatments for speech and swallowing: a tutorial.
HM Clark, Am J Speech Lang Pathol. 2003 Nov:400-15 |
| |
Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study.
GA Prasad, NJ Talley, Y Romero, AS Arora, LA Kryzer, TC Smyrk, JA Alexander, Am J Gastroenterol. 2007 Dec:2627-32 |
| |
Prevention of pneumonia in elderly stroke patients by systematic diagnosis and treatment of dysphagia: an evidence-based comprehensive analysis of the literature.
DL Doggett, KA Tappe, MD Mitchell, R Chapell, V Coates, CM Turkelson, Dysphagia. 2001 Fall:279-95 |
| |
Symptom-based outcome measures for dyspepsia and GERD trials: a systematic review.
A Fraser, B Delaney, P Moayyedi, Am J Gastroenterol. 2005 Feb:442-52 |
| |
Systematic review: Is there excessive use of proton pump inhibitors in gastro-oesophageal reflux disease?
TJ Lee, MB Fennerty, CW Howden, Aliment Pharmacol Ther. 2004 Dec:1241-51 |
| |
The gastro-oesophageal reflux disease impact scale: a patient management tool for primary care.
R Jones, K Coyne, I Wiklund, Aliment Pharmacol Ther. 2007 Jun 15:1451-9 |
| |
The prevalence of and the clinical and demographic characteristics associated with high-intensity proton pump inhibitor use.
LE Targownik, C Metge, L Roos, S Leung, Am J Gastroenterol. 2007 May:942-50 |
| |
Treatment for swallowing difficulties (dysphagia) in chronic muscle disease.
M Hill, T Hughes, C Milford, Cochrane Database Syst Rev. 2004:CD004303 |
| |
Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease.
KR DeVault, DO Castell, American College of Gastroenterology, Am J Gastroenterol. 2005 Jan:190-200 |